T cell infiltration is associated with increased Lyme arthritis in TLR2-/- mice

FEMS Immunology and Medical Microbiology

Volumn 52, Issue 1, 2008, Pages 124-133

  Wang, Xiaohui ^a   Ma, Ying ^a   Yoder, Alyson ^a   Crandall, Hillary ^a   Zachary, James F ^b   Fujinami, Robert S ^a   Weis, John H ^a   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Chemokines; IFN inducible genes; Lyme arthritis; T cells; TLR2 mice

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA BURGDORFERI; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; GENE; GENE MUTATION; IGTP GENE; JOINT; KNOCKOUT MOUSE; LYME DISEASE; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCID GENE; SYNOVIOCYTE; T LYMPHOCYTE; ULTRASOUND;

ANIMALS; ANKLE JOINT; BORRELIA BURGDORFERI; CHEMOKINE CXCL10; CHEMOKINE CXCL9; GTP PHOSPHOHYDROLASES; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2;

EID: 38149034510     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00356.x     Document Type: Article

References (38)

1. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E Flavell RA (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 8 : 878 884.
2. Anguita J, Persing DH, Rincon M, Barthold SW Fikrig E (1996) Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest 97 : 1028 1034.
3. Barthold SW Bockenstedt LK (1993) Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61 : 4696 4702.
4. Barthold SW, Beck DS, Hansen GM, Terwilliger GA Moody KD (1990) Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162 : 133 138.
5. Barthold SW, Sidman CL Smith AL (1992) Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 47 : 605 613.
6. Barthold SW, deSouza M Feng S (1996) Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 74 : 57 67.
7. Barthold SW, Feng S, Bockenstedt LK, Fikrig E Feen K (1997) Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis 25 : S9 S17.
8. Bolz DD, Sundsbak RS, Ma Y, Akira S, Kirschning CJ, Zachary JF, Weis JH Weis JJ (2004) MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 173 : 2003 2010.
9. Brown CR Reiner SL (1999a) Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect Immun 67 : 3329 3333.
10. Brown CR Reiner SL (1999b) Genetic control of experimental lyme arthritis in the absence of specific immunity. Infect Immun 67 : 1967 1973.
11. Brown CR, Blaho VA Loiacono CM (2003) Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol 171 : 893 901.
12. Brown CR, Blaho VA Loiacono CM (2004) Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1-polymorphonuclear leukocyte-like cells. Infect Immun 72 : 4956 4965.
13. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E Davis JP (1982) Lyme disease-a tick-borne spirochetosis? Science 216 : 1317 1319.
14. Butler DM, Malfait AM, Mason LJ, Warden PJ, Kollias G, Maini RN, Feldmann M Brennan FM (1997) DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J Immunol 159 : 2867 2876.
15. Chirgwin JM, Przybyla AE, MacDonald RJ Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 : 5294 5299.
16. Crandall H, Ma Y, Dunn DM, Sundsbak RS, Zachary JF, Olofsson P, Holmdahl R, Weis JH, Weiss RB, Teuscher C Weis JJ (2005) Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase. Am J Pathol 167 : 775 785.
17. Crandall H, Dunn DM, Ma Y, Wooten RM, Zachary JF, Weis JH, Weiss RB Weis JJ (2006) Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis. J Immunol 177 : 7930 7942.
18. Glickstein L, Edelstein M Dong JZ (2001) Gamma interferon is not required for arthritis resistance in the murine Lyme disease model. Infect Immun 69 : 3737 3743.
19. Gross DM, Forsthuber T, Tary-Lehmann M et al 1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281 : 703 706.
20. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, Klebanoff SJ Wilson CB (2001) Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166 : 15 19.
21. Keane-Myers A Nickell SP (1995) Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155 : 2020 2028.
22. Ma Y, Seiler KP, Eichwald EJ, Weis JH, Teuscher C Weis JJ (1998) Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun 66 : 161 168.
23. Matyniak JE Reiner SL (1995) T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 181 : 1251 1254.
24. McKisic MD, Redmond WL Barthold SW (2000) Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol 164 : 6096 6099.
25. Potter MR, Noben-Trauth N, Weis JH, Teuscher C Weis JJ (2000) Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes. Infect Immun 68 : 5603 5609.
26. Schaible UE, Kramer MD, Eichmann K, Modolell M, Museteanu C Simon MM (1990) Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Natl Acad Sci USA 87 : 3768 3772.
27. Schaible UE, Wallich R, Kramer MD, Nerz G, Stehle T, Museteanu C Simon MM (1994) Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol 6 : 671 681.
28. Shanafelt MC, Kang I, Barthold SW Bockenstedt LK (1998) Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect Immun 66 : 266 271.
29. Steere AC, Schoen RT Taylor E (1987) The clinical evolution of Lyme arthritis. Ann Intern Med 107 : 725 731.
30. Steere AC, Dwyer E Winchester R (1990) Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 323 : 219 223.
31. Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J Nepom GT (2003) Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 48 : 534 540.
32. Takeda K, Kaisho T Akira S (2003) Toll-like receptors. Annu Rev Immunol 21 : 335 376.
33. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL Akira S (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169 : 10 14.
34. Wang G, Ma Y, Buyuk A, McClain S, Weis JJ Schwartz I (2004) Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice. FEMS Microbiol Lett 231 : 219 225.
35. Wang X, Ma Y, Weis JH, Zachary JF, Kirschning CJ Weis JJ (2005) Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease. Infect Immun 73 : 657 660.
36. Werts C, Tapping RI, Mathison JC et al 2001) Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2 : 346 352.
37. Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R Weis JJ (1998) The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 160 : 5485 5492.
38. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ Weis JJ (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168 : 348 355.